Summary of Bill HRES 1200
Bill 118 HRES 1200, also known as the "Tardive Dyskinesia Awareness Week" bill, is a piece of legislation that aims to designate the week of May 5, 2024, through May 11, 2024, as a week dedicated to raising awareness about tardive dyskinesia. Tardive dyskinesia is a neurological disorder characterized by involuntary movements, often caused by long-term use of certain medications, particularly those used to treat mental health conditions.
The bill expresses support for increasing awareness about tardive dyskinesia and the impact it has on individuals who suffer from the condition. By designating a specific week for this purpose, the bill aims to educate the public, healthcare professionals, and policymakers about the symptoms, causes, and treatment options for tardive dyskinesia.
The bill does not propose any specific actions or funding allocations; rather, it serves as a symbolic gesture to bring attention to an often overlooked and misunderstood disorder. By raising awareness, the hope is that individuals with tardive dyskinesia will receive better support and understanding from their communities and healthcare providers.
Overall, Bill 118 HRES 1200 is a non-partisan effort to shed light on an important issue affecting many individuals in the United States. It emphasizes the importance of education and advocacy in addressing neurological disorders like tardive dyskinesia.
Congressional Summary of HRES 1200
This resolution supports the designation of Tardive Dyskinesia Awareness Week. Tardive dyskinesia is a movement disorder characterized by involuntary and uncontrolled movements of muscles in the face, torso, and extremities. It is caused by prolonged use of certain medications, including ones used to treat schizophrenia.